Mitchell H. Finer

2014

In 2014, Mitchell H. Finer earned a total compensation of $1.6M as Chief Scientific Officer at bluebird bio, a 46% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$141,568
Option Awards$1,101,170
Salary$327,885
Total$1,570,623

Finer received $1.1M in option awards, accounting for 70% of the total pay in 2014.

Finer also received $141.6K in non-equity incentive plan and $327.9K in salary.

Rankings

In 2014, Mitchell H. Finer's compensation ranked 5,552nd out of 13,032 executives tracked by ExecPay. In other words, Finer earned more than 57.4% of executives.

ClassificationRankingPercentile
All
5,552
out of 13,032
57th
Division
Manufacturing
1,985
out of 4,965
60th
Major group
Chemicals And Allied Products
671
out of 1,690
60th
Industry group
Drugs
520
out of 1,369
62nd
Industry
Biological Products, Except Diagnostic Substances
92
out of 241
62nd
Source: SEC filing on April 24, 2015.

Finer's colleagues

We found five more compensation records of executives who worked with Mitchell H. Finer at bluebird bio in 2014.

2014

Nick Leschly

bluebird bio

Chief Executive Officer

2014

James DeTore

bluebird bio

Chief Financial Officer

2014

Jason Cole

bluebird bio

General Counsel

2014

David Davidson

bluebird bio

Chief Medical Officer

2014

Jeffrey Walsh

bluebird bio

Chief Financial and Strategy Officer

In-depth

You may also like